The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Evolving role of uPA/uPAR system in human cancers
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Pulukuri, S. M., Gondi, C. S., Lakka, S. S., Jutla, A., Estes, N., Gujrati, M., & Rao, J. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503111200 · Cited by 285
RetractedKong, D., Li, Y., Wang, Z., Banerjee, S., & Sarkar, F. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4277 · Cited by 195
Self-citationRetractedGondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2004) · Oncogene · doi:10.1038/sj.onc.1207879 · Cited by 141
RetractedJemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Cancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955
Plasminogen Activators, Tissue Degradation, and Cancer
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60028-7 · Cited by 2,535
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
Bajou, K., Noël, A., Gerard, R. D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N. E., Carmeliet, P., Collen, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0898-923 · Cited by 677
Look, M. P., van Putten, W. L. J., Duffy, M. J., Harbeck, N., Christensen, I. J., Thomssen, C., Kates, R., Spyratos, F., Ferno, M., Eppenberger-Castori, S., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.2.116 · Cited by 596
Herz, J., Clouthier, D. E., & Hammer, R. E. (1992) · Cell · doi:10.1016/0092-8674(92)90511-a · Cited by 497
Janicke, F., Prechtl, A., Thomssen, C., Harbeck, N., Meisner, C., Untch, M., Sweep, C. G. J. F., Selbmann, H.-K., Graeff, H., & Schmitt, M. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.12.913 · Cited by 434
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.
Foekens, J. A., Peters, H. A., Look, M. P., Portengen, H., Schmitt, M., Kramer, M. D., Brünner, N., Jänicke, F., Gelder, M. E. M., Henzen-Logmans, S. C., et al. (2000) · PubMed · Cited by 419
Li, Y., Ahmed, F., Ali, S., Philip, P. A., Kucuk, O., & Sarkar, F. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4604 · Cited by 376
Self-citationRecycling of the urokinase receptor upon internalization of the uPA:serpin complexes
Nykjar, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2610 · Cited by 309
Structure of Human Urokinase Plasminogen Activator in Complex with Its Receptor
Huai, Q., Mazar, A. P., Kuo, A., Parry, G. C., Shaw, D. E., Callahan, J., Li, Y., Yuan, C., Bian, C., Chen, L., et al. (2006) · Science · doi:10.1126/science.1121143 · Cited by 308
The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent
Devy, L., Blacher, S., Grignet-Debrus, C., Bajou, K., Masson, V., Gerard, R. D., Gils, A., Carmeliet, G., Carmeliet, P., Declerck, P. J., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0552com · Cited by 280
Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis
Stephens, R. W. (1999) · Journal of the National Cancer Institute · doi:10.1093/jnci/91.10.869 · Cited by 279
Plasminogen Activator Inhibitor-1 Regulates Tumor Growth and Angiogenesis
McMahon, G. A., Petitclerc, E., Stefansson, S., Smith, E., Wong, M. K. K., Westrick, R. J., Ginsburg, D., Brooks, P. C., & Lawrence, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105980200 · Cited by 263
Llinas, P., Hélène Le Du, M., Gårdsvoll, H., Danø, K., Ploug, M., Gilquin, B., Stura, E. A., & Ménez, A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600635 · Cited by 237
uPAR – uPA – PAI-1 interactions and signaling: A vascular biologist’s view
Mihaly, J., Prager, G., & Binder, B. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-11-0669 · Cited by 236
Banerjee, S., Zhang, Y., Ali, S., Bhuiyan, M., Wang, Z., Chiao, P. J., Philip, P. A., Abbruzzese, J., & Sarkar, F. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1330 · Cited by 231
Self-citationUsing Chemopreventive Agents to Enhance the Efficacy of Cancer Therapy
Sarkar, F. H., & Li, Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4526 · Cited by 229
Self-citationCelecoxib and Curcumin Synergistically Inhibit the Growth of Colorectal Cancer Cells
Lev-Ari, S., Strier, L., Kazanov, D., Madar-Shapiro, L., Dvory-Sobol, H., Pinchuk, I., Marian, B., Lichtenberg, D., & Arber, N. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0171 · Cited by 221
Gutierrez, L. S., Schulman, A., Brito-Robinson, T., Noria, F., Ploplis, V. A., & Castellino, F. (2000) · PubMed · Cited by 217
Shariat, S. F., Roehrborn, C. G., McConnell, J. D., Park, S., Alam, N., Wheeler, T. M., & Slawin, K. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6853 · Cited by 209
Tissue plasminogen activator is a potent activator of PDGF‐CC
Fredriksson, L., Li, H., Fieber, C., Li, X., & Eriksson, U. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600397 · Cited by 193
Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
Stefansson, S., McMahon, G., Petitclerc, E., & Lawrence, D. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454621 · Cited by 169
Bajou, K., Maillard, C., Jost, M., Lijnen, R. H., Gils, A., Declerck, P., Carmeliet, P., Foidart, J.-M., & Noel, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207859 · Cited by 164
Jazirehi, A. R., & Bonavida, B. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.71.3.1 · Cited by 163
Indole-3-Carbinol and Prostate Cancer
Sarkar, F. H., & Li, Y. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.12.3493s · Cited by 158
Self-citationSoff, G. A., Sanderowitz, J., Gately, S. T., Verrusio, E., Weiss, I., Brem, S. S., & Kwaan, H. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118323 · Cited by 156
Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung Cancer
Gutova, M., Najbauer, J., Gevorgyan, A., Metz, M. Z., Weng, Y., Shih, C.-C., & Aboody, K. S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000243 · Cited by 141
Nykjær, A., Christensen, E. I., Vorum, H., Hager, H., Petersen, C. M., Røigaard-Petersen, H., Min, H. Y., Vilhardt, F., Møller, L. B., Kornfeld, S. A., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.3.815 · Cited by 141
Bauer, T. W., Liu, W., Fan, F., Camp, E. R., Yang, A. D., Somcio, R., Bucana, C. D., Callahan, J. A., Parry, G. C., Evans, D. B., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0946 · Cited by 137
Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion
Ishii, K., Usui, S., Sugimura, Y., Yoshida, S., Hioki, T., Tatematsu, M., Yamamoto, H., & Hirano, K. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200102)9999:9999<::aid-ijc1178>3.0.co;2-6 · Cited by 128
Carmeliet, P., Moons, L., Dewerchin, M. A., Rosenberg, S., Herbert, J., Lupu, F., & Collen, D. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.1.233 · Cited by 126
The urokinase plasminogen activator receptor as a gene therapy target for cancer
Pillay, V., Dass, C. R., & Choong, P. (2006) · Trends in biotechnology · doi:10.1016/j.tibtech.2006.10.011 · Cited by 109
Kobayashi, H., Fujishiro, S., & Terao, T. (1994) · PubMed · Cited by 107
Genetic and Plasma Markers of Venous Thromboembolism in Patients with High Grade Glioma
Sciacca, F. L., Ciusani, E., Silvani, A., Corsini, E., Frigerio, S., Pogliani, S., Parati, E. A., Croci, D., Boiardi, A., & Salmaggi, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0198 · Cited by 102
Chisholm, K. A., Bray, B. J., & Rosengren, R. J. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200410000-00010 · Cited by 98
Prognostic role of urokinase-type plasminogen activator in human gliomas.
Hsu, D., Efird, J. T., & Hedley‐Whyte, E. T. (1995) · PubMed · Cited by 93
Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism.
Roca, C., Primo, L., Valdembri, D., Cividalli, A., Declerck, P. J., Carmeliet, P., Gabriele, P., & Bussolino, F. (2003) · PubMed · Cited by 81
Fisher, J., Mackie, P. S., Howard, M. L., Zhou, H., & Choong, P. (2001) · PubMed · Cited by 78
Stillfried, G. E., Saunders, D. N., & Ranson, M. (2007) · Breast Cancer Research · doi:10.1186/bcr1647 · Cited by 73
The Urokinase-type Plasminogen Activator System in Prostate Cancer Metastasis
Sheng, S. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1015539612576 · Cited by 71
Margheri, F., D’Alessio, S., Serratì, S., Pucci, M., Annunziato, F., Cosmi, L., Liotta, F., Angeli, R., Angelucci, A., Gravina, G. L., et al. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302456 · Cited by 71
Harvey, S. R., Hurd, T. C., Markus, G., Martinick, M., Penetrante, R. M., Tan, D., Venkataraman, P., DeSouza, N., Sait, S. N. J., Driscoll, D. L., et al. (2003) · PubMed · Cited by 71
Structure of the Human Urokinase Receptor Gene and Its Similarity to CD59 and the Ly‐6 Family
Wang, Y., Dang, J., Johnson, L. K., Selhamer, J. J., & Doe, W. F. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20366.x · Cited by 70
Leik, C. E., Su, E. J., Nambi, P., Crandall, D., & Lawrence, D. A. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02244.x · Cited by 70
Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer
Memarzadeh, S., Kozak, K. R., Chang, L., Natarajan, S., Shintaku, P. I., Reddy, S. T., & Farias‐Eisner, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152127499 · Cited by 70
Duffy, M. J., Duggan, C. R., Mulcahy, H. E., McDermott, E. W. M., & O’Higgins, N. J. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.6.1177 · Cited by 62
Farias‐Eisner, R., Vician, L. J., Silver, A., Reddy, S. T., Rabbani, S. A., & Herschman, H. R. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00230.2000 · Cited by 61
Los, M., Zeamari, S., Foekens, J. A., Gebbink, M. F. B. G., & Voest, E. E. (1999) · PubMed · Cited by 43
Shiomi, H., Eguchi, Y., Tani, T., Kodama, M., & Hattori, T. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64761-x · Cited by 39
Zhang, L. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i25.3970 · Cited by 38
Plasminogen activator inhibitor-1 gene polymorphism and colorectal cancer risk and prognosis
Loktionov, A. S. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00556-6 · Cited by 38
Rømer, J., Pyke, C., Lund, L. R., Danø, K., & Ralfkiaer, E. M. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01241.x · Cited by 36
Graf, M., Reif, S., Hecht, K., Pelka‐Fleischer, R., Pfister, K., & Schmetzer, H. M. (2005) · American Journal of Hematology · doi:10.1002/ajh.20337 · Cited by 36
H�ckel, C. G., Krueger, S., Grote, H.-J., Oshiro, Y., Hodges, S., Johnston, D. A., Johnson, M. E., Roessner, A., Ayala, A. G., & Czerniak, B. A. (2000) · Cancer · Cited by 35
Swiercz, R., Wolfe, J. D., Zaher, A., & Jankun, J. (1998) · PubMed · Cited by 34
Nielsen, A., Scarlett, C. J., Samra, J. S., Gill, A. J., Li, Y., Allen, B., & Smith, R. C. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03531.x · Cited by 33
H�ckel, C. G., Czerniak, B. A., Ayala, A. G., Radig, K., & Roessner, A. (1997) · Cancer · Cited by 32
Aref, S., El-Sherbiny, M., Mabed, M., Menessy, A., & El‐Refaei, M. F. (2003) · Hematology · doi:10.1080/10245330310001621323 · Cited by 31
Riisbro, R., Christensen, I. J., Nielsen, H. J., Brünner, N., Nilbert, M. C., & Fernebro, E. (2005) · The International Journal of Biological Markers · doi:10.1177/172460080502000203 · Cited by 31
Leissner, P., Verjat, T., Bachelot, T., Paye, M., Krause, A., Puisieux, A., & Mougin, B. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-216 · Cited by 28
Bu, X., Khankaldyyan, V., Gonzales-Gomez, I., Groshen, S. G., Ye, W., Zhuo, S., Pons, J., Stratton, J., Rosenberg, S., & Laug, W. E. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700089 · Cited by 28
Ji, F. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i21.3222 · Cited by 28
Plasminogen activation in human acute leukaemias
Angelillo‐Scherrer, A., Wohlwend, A., Kruithof, E. K. O., Vassalli, J. D., & Sappino, A. P. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01432.x · Cited by 26
Perkins, R. C., Broaddus, V. C., Shetty, S., Hamilton, S., & Idell, S. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.21.5.3225 · Cited by 24
Ornstein, D. L., & Zacharski, L. R. (2007) · Nutrition and Cancer · doi:10.1080/01635580701308265 · Cited by 22
Cited by
Regulation of cell signalling by uPAR
Smith, H. W., & Marshall, C. J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2821 · Cited by 960
Senescence-messaging secretome: SMS-ing cellular stress
Kuilman, T., & Peeper, D. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2560 · Cited by 909
Obesity and cancer: the role of dysfunctional adipose tissue
van Kruijsdijk, R. C. M., van der Wall, E., & Visseren, F. L. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0372 · Cited by 715
Remarkable Potential of the α-Aminophosphonate/Phosphinate Structural Motif in Medicinal Chemistry
Mucha, A., Kafarski, P., & Berlicki, Ł. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200587f · Cited by 672
Wang, Z., Li, Y., Kong, D., Banerjee, S., Ahmad, A., Azmi, A. S., Ali, S., Abbruzzese, J. L., Gallick, G. E., & Sarkar, F. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4312 · Cited by 619
Self-citation
Metadata
- Authors
- Dass, K., Ahmad, A., Azmi, A. S., Sarkar, S. H., & Sarkar, F. H.
- Venue
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 34
- Issue
- 2
- Pages
- 122-136
- ISSN
- 0305-7372 (ISSN-L)
- OpenAlex
- W2085351616
- Cited by
- 423
- References
- 69
- FWCI
- 12.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.